|
MRPL46 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.946400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.398000E-02 |
| Normal-vs-Stage2 |
5.306300E-02 |
| Normal-vs-Stage3 |
1.122950E-01 |
| Normal-vs-Stage4 |
4.531200E-01 |
| Stage1-vs-Stage2 |
3.444000E-01 |
| Stage1-vs-Stage3 |
7.839200E-01 |
| Stage1-vs-Stage4 |
3.742100E-02 |
| Stage2-vs-Stage3 |
5.513000E-01 |
| Stage2-vs-Stage4 |
2.058300E-02 |
| Stage3-vs-Stage4 |
5.992200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.309900E-02 |
| Normal-vs-AfricanAmerican |
2.040000E-01 |
| Normal-vs-Asian |
2.210300E-02 |
| Caucasian-vs-AfricanAmerican |
7.355200E-01 |
| Caucasian-vs-Asian |
2.079200E-01 |
| AfricanAmerican-vs-Asian |
5.893200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.564600E-01 |
| Normal-vs-Female |
3.965900E-02 |
| Male-vs-Female |
2.265000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.436100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.853700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.174600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.696600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.436400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.742020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.294600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.839600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.218800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.313800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.109700E-02 |
| Classical-VS-Follicular |
2.016000E-03 |
| Classical-VS-Other |
8.509600E-02 |
| Classical-VS-Normal |
4.475600E-03 |
| Tall-VS-Follicular |
4.369800E-01 |
| Tall-VS-Other |
2.147400E-01 |
| Tall-VS-Normal |
6.756600E-01 |
| Follicular-VS-Other |
5.406200E-01 |
| Follicular-VS-Normal |
6.371600E-01 |
| Other-VS-Normal |
2.401600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.172100E-02 |
| Normal-vs-N1 |
5.829500E-02 |
| N0-vs-N1 |
1.556170E-03 |
|
|
